Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations

 We inform that the Members of the Company in the 33rd Annual General Meeting held on 28th September, 2020, has approved the re-appointment of Mr. Fredun Medhora, Managing Director of the Company for further period of 3 years with effect from 15th October, 2020. Further, as per the requirement of the Circular No. ListlComp11412018-19 dated June, 20, 2018 issued by respective Stock Exchange on the subject of enforcement of SEBl Orders regarding appointment of Directors by listed companies we hereby affirm that the Directors getting appointed or re-appointed are not debarred from holding the office of director by virtue of any order of SEBl or any other such authority.
14-10-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Shareholding for the Period Ended September 30, 2020

 Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here
12-10-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Compliance Certificate For The Period Ended September 2020

 In compliance to Regulation 7(3) of SEBI Listing Regulations, 2015; we furnish hereunder the Certificate, duly signed by the Company Secretary of Fredun Pharmaceuticals Limited and by the Compliance Officer of 'Purva Sharegistry (India) Pvt. Ltd.', designated Share Transfer Agent of the Company for the half year ended September 30, 2020.
12-10-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; we furnish hereunder the confirmation certificate received from the SEBI Registered Share Transfer Agent viz. Purva Sharegistry (India) Pvt. Ltd. for the quarter ended September 30, 2020.
05-10-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Statement Of Investor Complaints For The Quarter Ended September 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ankita JoshiDesignation :- Company Secretary and Compliance Officer
05-10-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 In compliance to Regulation 44(3) of SEBI Listing Regulations, 2015; we hereby submit the Voting Results of the of the business transacted at the 33rd Annual General Meeting (the '33rd AGM') of the Company for the Financial Year 2019-20 held on Monday, September 28, 2020.
30-09-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Fredun Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
29-09-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window

 Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, and 'Code of Conduct for Prevention of Insider Trading' of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company), the trading window for dealing in securities of the Company will remain closed for designated persons and their immediate relatives with effect from 1st October, 2020 till 48 hours after the end of the Board Meeting wherein; the approval of Un-audited Financial Results for the Quarter and Half Year ended 30th September, 2020, would be considered, approved and declared.
28-09-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 Pursuant to Regulation 30 read with Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the summary of the proceedings of 33rd Annual General Meeting of the Company held on Monday, September 28, 2020 at 11:00am (IST) through Video Conferencing ('VC').
28-09-2020
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In compliance to Regulation 47(1)(b) of SEBI Listing Regulations, 2015; we enclose herewith the copies of the Newspaper cuttings of the Financials Results of the Company for the Quarter ended June 2020; as approved by the Board in its Meeting held on Tuesday, September 15, 2020; published in Business Standard & Mumbai Lakshadeep newspaper(s) on September 17, 2020.
17-09-2020
Next Page
Close

Let's Open Free Demat Account